The Implied Analyst 12-Month Target For XHE

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR S&P Health Care Equipment ETF ( XHE), we found that the implied analyst target price for the ETF based upon its underlying holdings is $56.57 per unit.

START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »

With XHE trading at a recent price near $49.28 per unit, that means that analysts see 14.79% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of XHE's underlying holdings with notable upside to their analyst target prices are Endologix Inc. ( ELGX), Orthofix International N.V. ( OFIX), and Globus Medical Inc ( GMED). Although ELGX has traded at a recent price of $9.84/share, the average analyst target is 47.36% higher at $14.50/share. Similarly, OFIX has 33.58% upside from the recent share price of $37.43 if the average analyst target price of $50.00/share is reached, and analysts on average are expecting GMED to reach a target price of $25.00/share, which is 18.54% above the recent price of $21.09. Below is a twelve month price history chart comparing the stock performance of ELGX, OFIX, and GMED:

ELGX, OFIX, and GMED Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

If you liked this article you might like

Rare Bipartisan Unison This Week in Congress Is a Bonanza for This One Stock

12 Best Biotech and Health Care ETFs to Add to Your Portfolio

9 Newly Rated ETFs For Your Portfolio